- Home
- BCRX vs PHIN Comparison
BCRX vs PHIN Comparison
Compare BCRX & PHIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- PHIN
- Stock Information
- Founded
- BCRX 1986
- PHIN 2023
- Country
- BCRX United States
- PHIN United States
- Employees
- BCRX N/A
- PHIN N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- PHIN
- Sector
- BCRX Health Care
- PHIN
- Exchange
- BCRX Nasdaq
- PHIN Nasdaq
- Market Cap
- BCRX 1.5B
- PHIN 1.8B
- IPO Year
- BCRX 1994
- PHIN N/A
- Fundamental
- Price
- BCRX $7.45
- PHIN $51.41
- Analyst Decision
- BCRX Buy
- PHIN Buy
- Analyst Count
- BCRX 6
- PHIN 2
- Target Price
- BCRX $15.17
- PHIN $53.50
- AVG Volume (30 Days)
- BCRX 2.3M
- PHIN 579.0K
- Earning Date
- BCRX 02-24-2025
- PHIN 02-13-2025
- Dividend Yield
- BCRX N/A
- PHIN 1.95%
- EPS Growth
- BCRX N/A
- PHIN N/A
- EPS
- BCRX N/A
- PHIN 2.34
- Revenue
- BCRX $412,579,000.00
- PHIN $3,452,000,000.00
- Revenue This Year
- BCRX $38.01
- PHIN N/A
- Revenue Next Year
- BCRX $19.04
- PHIN $1.04
- P/E Ratio
- BCRX N/A
- PHIN $21.93
- Revenue Growth
- BCRX 29.92
- PHIN N/A
- 52 Week Low
- BCRX $4.03
- PHIN $28.23
- 52 Week High
- BCRX $8.88
- PHIN $57.23
- Technical
- Relative Strength Index (RSI)
- BCRX 47.51
- PHIN 58.22
- Support Level
- BCRX $7.53
- PHIN $46.74
- Resistance Level
- BCRX $8.02
- PHIN $52.42
- Average True Range (ATR)
- BCRX 0.44
- PHIN 1.25
- MACD
- BCRX -0.06
- PHIN 0.55
- Stochastic Oscillator
- BCRX 32.03
- PHIN 82.83
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About PHIN PHINIA Inc.
Phinia Inc is a leader in the development, design, and manufacture of integrated components and systems that optimize performance, increase efficiency, and reduce emissions in combustion and hybrid propulsion for commercial vehicles and industrial applications, and light vehicles. It is a global supplier to most major original equipment manufacturers (OEMs) and offers a wide range of original equipment service (OES) solutions and remanufactured products as well as an expanded range of products for the independent (non-OEM) aftermarket. Phinia has an extensive original equipment portfolio of advanced fuel injection systems, fuel delivery modules, canisters, starters, alternators, sensors, electronic control modules, and associated software.